Global Medical Devices Outsourcing Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Service;
Quality Assurance, Regulatory Affairs Services, Product Testing & Sterilization Services, and Product Implementation Services.By Class;
Class I, Class II and Class III.By Product;
Finished Goods, Electronics, and Raw Materials.By Application;
Cardiology, Diagnostic Imaging, Orthopaedic, IVD, Ophthalmic, General, Plastic Surgery, Drug Delivery, Dental, Endoscopy, Diabetes Care, and Others.By End User;
Small Medical Device Company, Medium Medical Device Company, Large Medical Device Company, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Medical Devices Outsourcing Market (USD Million), 2021 - 2031
In the year 2023, the Global Medical Devices Outsourcing Market was valued at USD 80,538.44 million. The size of this market is expected to increase to USD 172,880.14 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 11.5%.
Amidst a landscape marked by escalating demand for cutting-edge medical technologies, fueled by factors like aging populations and advancements in treatments, outsourcing emerges as a cornerstone for companies striving to maintain relevance in the global market. By entrusting non-core functions to proficient partners, firms can focus on core competencies such as research, innovation, and commercialization, thus fostering agility and accelerating time-to-market for novel medical devices.
The spectrum of outsourcing in medical devices encompasses a broad array of activities, ranging from contract manufacturing to regulatory affairs and quality assurance. Contract manufacturing, for instance, enables companies to harness the manufacturing capabilities of specialized organizations, ensuring efficient and cost-effective production while freeing up internal resources for strategic initiatives. Additionally, outsourcing facilitates access to specialized skills and knowledge, particularly in navigating the intricate regulatory landscape and ensuring adherence to rigorous quality standards.
Globalization and the rise of new markets present lucrative prospects for the medical devices outsourcing sector. With the expansion of healthcare infrastructure in emerging economies, there is a burgeoning demand for high-quality, affordable medical devices. This trend underscores the significance of forging strategic partnerships and collaborations, which not only enable companies to capitalize on new market opportunities but also foster innovation and adaptability in response to evolving customer demands.
Global Medical Devices Outsourcing Market Recent Developments
-
In May 2023, Emergo collaborated with the Shanghai Center for Medical Testing and Inspection (CMTC) for ongoing usability testing of medical devices in China. This collaboration was expected to ensure usability testing by following the Human Factors Engineering (HFE) guidelines outlined by China’s National Medical Products Administration (NMPA).
-
In September 2022, North American Science Associates, LLC' (NAMSA) and InspireMD, Inc. announced an outsourcing partnership to accelerate medical device development & commercialization.
Segment Analysis
The Global Medical Devices Outsourcing Market has been segmented by service, class, product, application, and end user, reflecting the diverse dynamics and specialized requirements of the industry.
By service, the market encompasses research and development (R&D), regulatory consulting, product testing and certification, manufacturing, quality assurance, and supply chain management. The R&D segment is driven by the increasing demand for innovative and technologically advanced medical devices, while regulatory consulting services help manufacturers navigate complex compliance standards across different regions. Manufacturing outsourcing remains a key focus area, allowing companies to scale production cost-effectively while maintaining high-quality standards.
By class, the market is categorized into Class I, Class II, and Class III medical devices, based on risk and regulatory complexity. Class I devices, such as bandages and stethoscopes, represent the least complex segment, requiring minimal regulatory oversight. Class II devices, including diagnostic imaging tools and surgical instruments, constitute a significant portion of outsourcing activities due to stringent requirements for efficacy and safety. Class III devices, like implantable devices and life-sustaining equipment, represent the most regulated and critical segment, often requiring sophisticated testing and precision manufacturing capabilities.
By product, the segmentation includes surgical instruments, diagnostic devices, therapeutic devices, and monitoring devices, among others. Outsourcing in the surgical instruments segment is bolstered by the growing demand for high-precision instruments used in minimally invasive surgeries. Diagnostic devices, including imaging systems and point-of-care testing tools, are witnessing robust outsourcing due to technological advancements and the need for rapid development cycles. Therapeutic and monitoring devices also contribute significantly to the market, driven by the rise of chronic diseases and increasing homecare solutions.
By end user, the market serves original equipment manufacturers (OEMs), hospitals, ambulatory surgical centers, and research organizations. OEMs are the primary contributors to the market, leveraging outsourcing to reduce operational costs and focus on core competencies like innovation and branding. Healthcare providers, including hospitals and clinics, also play a crucial role in driving demand, particularly for customized devices tailored to specific patient needs.
This comprehensive segmentation highlights the pivotal role of outsourcing in addressing cost pressures, regulatory complexities, and the demand for innovation in the medical devices sector. With increasing reliance on outsourcing, the market is poised for significant growth, supported by advancements in technology and expanding healthcare infrastructure globally.
Global Medical Devices Outsourcing Segment Analysis
In this report, the Global Medical Devices Outsourcing Market has been segmented by Service, Class, Product, Application, End User and Geography.
Global Medical Devices Outsourcing Market, Segmentation by Service
The Global Medical Devices Outsourcing Market has been segmented by Service into Quality Assurance, Regulatory Affairs Services, Product Testing & Sterilization Services, and Product Implementation Services.
Regulatory Affairs Services are crucial for navigating the complex regulatory landscape governing medical devices. Outsourcing regulatory affairs tasks to specialized service providers helps manufacturers ensure compliance with evolving regulations, streamline the regulatory approval process, and expedite market entry for new products. These services encompass regulatory strategy development, submission preparation, regulatory intelligence, and compliance monitoring, enabling companies to navigate global regulatory requirements seamlessly.
Product Testing & Sterilization Services play a pivotal role in verifying the safety, efficacy, and performance of medical devices. Outsourcing product testing tasks to accredited laboratories and sterilization facilities ensures rigorous testing protocols and adherence to industry standards. These services include biocompatibility testing, performance testing, shelf-life studies, and sterilization validation, ensuring that medical devices meet regulatory requirements and pose minimal risks to patients and healthcare providers.
Product Implementation Services encompass activities related to the deployment, installation, and integration of medical devices into healthcare settings. Outsourcing implementation tasks to experienced service providers ensures smooth and efficient deployment, minimizing disruption to clinical workflows and maximizing the benefits of new medical technologies. These services may include installation, training, user support, and ongoing maintenance, ensuring optimal performance and user satisfaction with medical devices.
Global Medical Devices Outsourcing Market, Segmentation by Class
The Global Medical Devices Outsourcing Market has been segmented by Class into Class I, Class II and Class III.
Class I devices pose the lowest risk to patients and are subject to the least stringent regulatory controls. These devices include low-risk products such as tongue depressors, bandages, and examination gloves. Outsourcing services for Class I devices may focus on basic manufacturing processes, quality control, and documentation compliance, ensuring that products meet minimal regulatory requirements while maintaining efficiency and cost-effectiveness.
Class II devices pose moderate risks to patients and are subject to higher regulatory controls compared to Class I devices. These devices include products such as infusion pumps, surgical gloves, and ultrasound equipment. Outsourcing services for Class II devices often involve more complex manufacturing processes, regulatory compliance activities, and quality assurance measures to ensure product safety and effectiveness. Service providers may offer specialized expertise in areas such as design control, risk management, and validation testing to support regulatory submissions and market approvals.
Class III devices pose the highest risks to patients and are subject to the most stringent regulatory controls. These devices include implantable devices such as pacemakers, artificial heart valves, and implantable infusion pumps. Outsourcing services for Class III devices require comprehensive expertise in regulatory affairs, quality management systems, and manufacturing processes to ensure compliance with stringent regulatory requirements and standards. Service providers may offer specialized services such as pre-market approval (PMA) submissions, clinical trial management, and post-market surveillance to support the development, approval, and commercialization of Class III medical devices.
Global Medical Devices Outsourcing Market, Segmentation by Product
The Global Medical Devices Outsourcing Market has been segmented by Product into Finished Goods, Electronics, and Raw Materials.
Finished Goods outsourcing focuses on the production of complete medical devices, including surgical instruments, diagnostic devices, and therapeutic equipment. Companies rely on third-party manufacturers to deliver ready-to-market products, enabling cost savings, faster production timelines, and scalability to meet market demands.
Electronics outsourcing addresses the growing need for advanced electronic components in medical devices, such as circuit boards, sensors, and microchips. With the rise of digital healthcare and wearable medical technologies, outsourcing electronics production ensures access to specialized expertise and state-of-the-art technology.
Raw Materials outsourcing involves sourcing essential materials such as metals, plastics, and biocompatible substances. This segment is crucial for maintaining the quality and performance of medical devices while optimizing costs. Reliable raw material suppliers are critical for ensuring consistency and compliance with stringent industry standards.
This segmentation captures the diverse outsourcing needs of the medical device industry, reflecting its reliance on specialized external partners to optimize operations and maintain competitive advantage.
Global Medical Devices Outsourcing Market, Segmentation by Application
The Global Medical Devices Outsourcing Market has been segmented by Application into Cardiology, Diagnostic Imaging, Orthopaedic, IVD (In Vitro Diagnostics), Ophthalmic, General, Plastic Surgery, Drug Delivery, Dental, Endoscopy, Diabetes Care, and Others.
Cardiology outsourcing includes the production of devices such as pacemakers, stents, and cardiac monitoring systems, addressing the rising prevalence of cardiovascular diseases globally. The growing demand for these devices, combined with the need to meet stringent regulatory standards, drives outsourcing in this sector. Companies benefit from the ability to focus on innovation and the rapid scaling of production while maintaining cost efficiency and compliance with global regulatory frameworks.
Diagnostic Imaging outsourcing focuses on advanced imaging devices such as CT scanners, MRI machines, and ultrasound systems. This segment benefits from outsourcing by ensuring the rapid integration of cutting-edge technology into medical devices. Outsourcing allows companies to remain competitive by leveraging the expertise and resources of third-party providers, ensuring that medical imaging systems meet the evolving demands of healthcare professionals and patients, while maintaining high standards of performance and reliability.
Orthopaedic applications involve the production of prosthetics, implants, and support devices, particularly in the context of joint replacement and trauma care. The aging global population, coupled with increasing demand for advanced joint replacement procedures, drives outsourcing in this sector. Outsourcing helps companies ensure the use of high-quality materials and precision engineering, reducing production costs while meeting the rising demand for orthopedic devices.
IVD (In Vitro Diagnostics) outsourcing includes the production of devices and consumables used for laboratory and point-of-care diagnostics. With the expanding market for personalized medicine and rapid diagnostics, outsourcing plays a critical role in driving innovation and scalability in the production of IVD devices. This sector benefits from the ability to quickly adapt to changing technological advancements, improve time-to-market, and manage costs effectively.
Ophthalmic outsourcing caters to the production of products like intraocular lenses, diagnostic equipment, and surgical tools, ensuring high precision and compliance with safety regulations. As the demand for advanced vision care solutions grows, outsourcing allows companies to leverage specialized manufacturing expertise, ensuring top-quality products for ophthalmic procedures.
Plastic Surgery and Drug Delivery outsourcing includes the production of specialized instruments and delivery systems. Outsourcing enables companies in these sectors to streamline manufacturing processes, ensuring the efficient production of medical devices used in cosmetic procedures and therapeutic drug delivery systems.
Dental outsourcing addresses the production of dental implants, aligners, and imaging equipment. With the increasing demand for advanced and aesthetic dental care solutions, outsourcing helps meet the need for high-quality dental devices at competitive prices, allowing companies to focus on research, development, and customer engagement.
Endoscopy and Diabetes Care applications rely on outsourcing for the development of minimally invasive devices and glucose monitoring systems. These advancements improve patient outcomes by enabling precise diagnoses and monitoring, while outsourcing supports the scaling of production to meet growing global demand.
The Others segment includes emerging applications in areas such as neurology and wound care, reflecting the versatility of outsourcing solutions across various medical specialties. This demonstrates how outsourcing can address diverse technological, regulatory, and production needs across a wide range of medical applications globally.
Global Medical Devices Outsourcing Market, Segmentation by End User
The Global Medical Devices Outsourcing Market has been segmented by End User into Small Medical Device Company, Medium Medical Device Company, Large Medical Device Company, and Others.
Small Medical Device Companies often rely on outsourcing to access specialized expertise and manufacturing capabilities that they may not have in-house. This segment benefits from cost-effective solutions, quicker time-to-market, and the ability to scale production as needed. Small companies typically outsource components, assembly, and testing of medical devices to enhance operational efficiency and reduce capital expenditures. By outsourcing, these companies can focus on innovation, product development, and marketing, without the significant investment in manufacturing infrastructure.
Medium Medical Device Companies tend to outsource specific functions such as design, regulatory compliance, and manufacturing to third-party service providers. These companies usually seek to optimize their supply chain, reduce costs, and expand their product offerings without significantly increasing operational complexity. Outsourcing in this segment allows medium-sized companies to focus on core business activities like innovation and marketing, while leveraging external expertise for production and ensuring regulatory compliance. This approach provides them with the flexibility to remain competitive without overextending their resources.
Large Medical Device Companies often outsource non-core activities, including manufacturing, assembly, and packaging, while focusing on their core competencies such as research and development (R&D), product development, and marketing. By partnering with external service providers, large companies benefit from increased production capacity, global reach, and operational flexibility. They typically engage with outsourcing partners for large-scale production and global distribution, ensuring efficiency and compliance with regulatory standards. Outsourcing also allows large companies to manage costs effectively while maintaining focus on their strategic priorities.
The Others segment includes a variety of different-sized companies or niche players in the medical device industry, such as contract manufacturers, startups, or companies involved in specific medical technologies. These end users might outsource specialized or low-volume manufacturing tasks, particularly in niche areas such as diagnostics, wearable health devices, or complex surgical instruments. This segment also reflects growing trends like personalized medicine and emerging technologies, where outsourcing plays a crucial role in scaling production and managing costs effectively. These players leverage outsourcing to remain agile and efficient in meeting market demands.
This segmentation highlights how different-sized companies in the medical device industry utilize outsourcing to enhance their capabilities, reduce costs, and remain competitive in an increasingly complex and regulated market.
Global Medical Devices Outsourcing Market, Segmentation by Geography
In this report, the Global Medical Devices Outsourcing Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Medical Devices Outsourcing Market Share (%), by Geographical Region, 2024
North America dominates the global medical devices outsourcing market, owing to its advanced healthcare infrastructure, established regulatory frameworks, and presence of major medical device manufacturers. The region benefits from a highly skilled workforce, robust research and development capabilities, and strong collaborations between industry stakeholders and academic institutions. Outsourcing services in North America focus on innovation, quality assurance, and regulatory compliance, catering to the diverse needs of medical device companies.
Europe represents another significant market for medical devices outsourcing, characterized by a well-developed healthcare system, stringent regulatory requirements, and a highly competitive landscape. The region boasts a strong presence of contract manufacturing organizations (CMOs) and regulatory consulting firms, offering a wide range of outsourcing services to support the development, manufacturing, and commercialization of medical devices. Outsourcing activities in Europe encompass a broad spectrum of services, including product design, testing, sterilization, and regulatory affairs.
The Asia Pacific region is witnessing rapid growth in the medical devices outsourcing market, driven by factors such as increasing healthcare expenditures, rising demand for affordable medical devices, and expanding manufacturing capabilities. Countries like China, India, and Singapore are emerging as key outsourcing hubs, leveraging their skilled workforce, cost-effective manufacturing facilities, and favorable regulatory environments to attract investments from multinational companies. Outsourcing services in Asia Pacific focus on contract manufacturing, supply chain management, and regulatory compliance, catering to both domestic and international markets.
The Middle East and Africa region is experiencing growing demand for medical devices outsourcing services, fueled by investments in healthcare infrastructure, rising prevalence of chronic diseases, and government initiatives to enhance healthcare accessibility and affordability. Outsourcing activities in the region are primarily focused on contract manufacturing, product testing, and regulatory consulting services, supporting the development and commercialization of medical devices tailored to local market needs.
Latin America presents opportunities for medical devices outsourcing, driven by improving healthcare infrastructure, expanding medical tourism industry, and favorable regulatory reforms. Countries like Brazil, Mexico, and Colombia are emerging as key outsourcing destinations, offering cost-effective manufacturing solutions and access to skilled labor. Outsourcing services in Latin America encompass a wide range of activities, including contract manufacturing, regulatory compliance, and market access support, catering to the growing demand for high-quality medical devices in the region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Medical Devices Outsourcing Market. These factors include; Market Drivers, Restraints and Opportunities.
Drivers:
- Cost Efficiency
- Access to Expertise
-
Accelerated Time-to-Market - Outsourcing allows medical device companies to leverage the expertise, resources, and infrastructure of external partners, thereby accelerating product development cycles and shortening time-to-market. By collaborating with experienced contract manufacturers, design firms, and regulatory consultants, companies can expedite prototyping, engineering, and validation processes, ensuring rapid progress from concept to commercialization. Outsourcing manufacturing tasks to facilities equipped with advanced technologies and scalable production capabilities enables companies to meet demand fluctuations and respond quickly to market opportunities, avoiding delays associated with in-house production constraints.
Outsourcing regulatory affairs services to knowledgeable consultants facilitates efficient navigation of complex regulatory pathways and expedites regulatory submissions and approvals. Regulatory experts can provide valuable guidance on compliance requirements, submission strategies, and documentation standards, helping companies anticipate regulatory hurdles and address them proactively. This streamlined regulatory approval process enables companies to bring new medical devices to market faster, gaining a competitive edge and maximizing revenue potential.
Outsourcing enables companies to focus on core competencies such as research, innovation, and commercialization, while delegating non-core functions to external partners. This strategic allocation of resources allows companies to optimize their internal capabilities and accelerate the development of breakthrough technologies, driving innovation and differentiation in the market.
Restraints:
- Quality Control Risks
- Intellectual Property Concerns
-
Dependency on Suppliers - One of the primary challenges associated with dependency on suppliers is the risk of supply chain disruptions. Medical device manufacturers often rely on a network of suppliers for critical components, materials, and services essential for the production of medical devices. Any disruptions in the supply chain, whether due to natural disasters, geopolitical tensions, or unforeseen events, can lead to delays in production, shortages of critical components, and interruptions in product availability. Such disruptions not only affect manufacturing schedules but also have the potential to impact patient care and safety if essential medical devices become unavailable.
Dependency on suppliers can pose risks related to quality control and product consistency. Medical device manufacturers must ensure that their suppliers adhere to stringent quality standards, regulatory requirements, and ethical practices to maintain the integrity and safety of their products. Failure to adequately vet and monitor suppliers can result in subpar quality, non-compliance issues, and product recalls, tarnishing the reputation of the manufacturer and compromising patient trust.
Dependency on suppliers can limit the flexibility and agility of medical device manufacturers in responding to changing market dynamics and customer demands. Relying heavily on external suppliers may hinder innovation, customization, and product differentiation, as manufacturers may be constrained by the capabilities and limitations of their suppliers. This dependency can stifle innovation and hinder the ability of manufacturers to introduce new products or adapt existing ones to evolving market needs and technological advancements.
Opportunities:
- Emerging Markets Expansion
- Technological Advancements
-
Personalized Medicine Trends - Personalized medicine, also known as precision medicine, involves tailoring medical treatment and interventions to individual patient characteristics, such as genetics, lifestyle, and environmental factors. This approach aims to optimize treatment outcomes, minimize adverse effects, and improve patient satisfaction by delivering targeted therapies and interventions tailored to each patient's unique needs.
One key aspect of personalized medicine trends is the increasing demand for customized medical devices and solutions that align with individual patient profiles. Outsourcing providers have the opportunity to collaborate with medical device manufacturers to develop personalized medical devices, diagnostics, and treatments that leverage advanced technologies and biomaterials. These customized solutions may include implantable devices, wearable sensors, diagnostic tools, and drug delivery systems designed to address specific patient conditions and preferences.
Personalized medicine trends drive the need for specialized expertise and capabilities in areas such as data analytics, biomaterials science, and regulatory affairs. Outsourcing providers can leverage their expertise to support medical device manufacturers in analyzing patient data, designing personalized interventions, and navigating regulatory requirements for personalized medical devices. By offering specialized services tailored to personalized medicine trends, outsourcing providers can differentiate themselves in the market and establish strategic partnerships with medical device companies seeking to capitalize on emerging opportunities in precision medicine.
Competitive Landscape Analysis
Key players in Global Medical Devices Outsourcing Market include:
- SGS SA
- Laboratory Corporation of America Holdings
- Euro fins Scientific
- Pace Analytical Services, Inc.
- Intertek Group plc
- WuXiAppTec
- North American Science Associates, LLC
- TÜV SÜD
- Sterigenics U.S., LLC (GTCR, LLC)
- Charles River Laboratories
- Medical Device Testing Services
- RJR Consulting, Inc.
- Mandala International
- Freyr
- Global Regulatory Partners
- PAREXEL International Corporation
- Emergo (UL LLC)
- Bioteknica
- Accell Clinical Research, LLC
- Genpact
- Criterium, Inc.
- Promedica International
- Med pace
- ICON plc.
- IQVIA Inc.
- Integer Holdings Corporation
- Tecomet Inc.
- Jabil Inc.
- FLEX LTD.
- Celestica Inc.
- Sanmina Corporation
- Plexus Corp.
- Phillips Medisize (Molex, LLC)
- Cantel Medical Corp. (STERIS plc)
- West Pharmaceutical Services, Inc.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Service
- Market Snapshot, By Class
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Medical Devices Outsourcing Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Cost Efficiency
-
Access to Expertise
-
Accelerated Time-to-Market
-
- Restraints
-
Quality Control Risks
-
Intellectual Property Concerns
-
Dependency on Suppliers
-
- Opportunities
-
Emerging Markets Expansion
-
Technological Advancements
-
Personalized Medicine Trends
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Medical Devices Outsourcing Market, By Service, 2021 - 2031 (USD Million)
- Quality Assurance
- Regulatory Affairs Services
- Product Testing & Sterilization Services
- Product Implementation Services
- Global Medical Devices Outsourcing Market, By Class, 2021 - 2031 (USD Million)
- Class I
- Class II
- Class III
- Global Medical Devices Outsourcing Market, By Product, 2021 - 2031 (USD Million)
- Finished Goods
- Electronics
- Raw Materials
- Global Medical Devices Outsourcing Market, By Application, 2021 - 2031 (USD Million)
- Cardiology
- Diagnostic Imaging
- Orthopaedic
- IVD
- Ophthalmic
- General
- Plastic Surgery
- Drug Delivery
- Dental
- Endoscopy
- Diabetes Care
- Others
- Global Medical Devices Outsourcing Market, By End User, 2021 - 2031 (USD Million)
- Small Medical Device Company
- Medium Medical Device Company
- Large Medical Device Company
- Others
- Global Medical Devices Outsourcing Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Medical Devices Outsourcing Market, By Service, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- SGS SA
- Laboratory Corporation of America Holdings
- Euro fins Scientific
- Pace Analytical Services, Inc.
- Intertek Group plc
- WuXiAppTec
- North American Science Associates, LLC
- TÜV SÜD
- Sterigenics U.S., LLC (GTCR, LLC)
- Charles River Laboratories
- Medical Device Testing Services
- RJR Consulting, Inc.
- Mandala International
- Freyr
- Global Regulatory Partners
- PAREXEL International Corporation
- Emergo (UL LLC)
- Bioteknica
- Accell Clinical Research, LLC
- Genpact
- Criterium, Inc.
- Promedica International
- Med pace
- ICON plc.
- IQVIA Inc.
- Integer Holdings Corporation
- Tecomet Inc.
- Jabil Inc.
- FLEX LTD.
- Celestica Inc.
- Sanmina Corporation
- Plexus Corp.
- Phillips Medisize (Molex, LLC)
- Cantel Medical Corp. (STERIS plc)
- West Pharmaceutical Services, Inc.
- Company Profiles
- Analyst Views
- Future Outlook of the Market